Ascension St. Vincent | ClinicalTrials HQ

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 3	2026-09-30		NCT05836987
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)	Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy	Active, not recruiting	Phase 3	2026-09-22		NCT06081894
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery	Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, heart failure, ischemic disease, myocardial infarction, myocardial ischemia, systolic heart failure, vascular disorder	Not yet recruiting	Not applicable	2026-09-10		NCT06965504
Aventus Thrombectomy System Pulmonary Embolism Clinical Study	Embolism, Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder	Active, not recruiting	Not applicable	2026-09-04		NCT05907564
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)	Hypoxia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder	Recruiting	Not stated	2026-08-26		NCT06388421
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Active, not recruiting	Phase 2	2026-07-30		NCT05154487
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation	cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency	Active, not recruiting	Not applicable	2026-07-23		NCT03433274
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 3	2026-06-26		NCT04045665
AMEND TS Early Feasibility Study	cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency	Recruiting	Not applicable	2026-01-07		NCT06951672
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy	cardiovascular disorder, heart disorder, heart failure	Active, not recruiting	Not stated	2025-11-20		NCT03970343
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)	DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, female reproductive system disorder, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease, vulvar disease	Recruiting	Phase 2	2025-08-14		NCT06075264